NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT03422679 2024-01-16Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesCellestia Biotech AGPhase 1/2 Terminated79 enrolled 22 charts
NCT03680560 2020-03-31Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor CancersCogent Biosciences, Inc.Phase 1 Terminated6 enrolled